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1. rntroduction 
Prostaglandins have been implicated in many cellu- 
lar control processes and the differential roles of the 
E series and F, series prostaglandins in their effects 
on DNA synthesis and cell division have been well 
studied [l-l]. Both affect the intracellular pools of 
cyclic nucleotides. PGEr markedly increases the 
accumulation of CAMP and stimulates adenyl cyclase 
activity in rat lymphnode lymphocytes [5], and 
increases CAMP levels in tonsillar lymphocytes [6] 
and in transformed 3T3 cells [7]. PGFza has been 
reported to cause cGMP accumulation in 3T3 cells [ 11. 
Several lines of evidence have suggested that syn- 
thesis of endogenous prostaglandins may play a part 
in lymphocyte stimulation. Enhanced accumulation 
of PGE has been found [8] in cultures of mouse 
spleen cells stimulated with endotoxin or concanavalin 
for 1 or 2 days and a very large increase in splenic 
PGFza has been reported within minutes of injection 
of sheep erythrocytes into sensitized mice [9,10]. 
Aspirin, an inhibitor of prostaglandin synthesis, inhibits 
mitogen- and antigen-stimulated [3H]thymidine incor- 
poration by human blood lymphocytes [ 111, while 
another inhibitor of prostaglandin synthesis, indo- 
methacin, inhibits DNA synthesis in cultured mouse 
tibroblasts [l]. Changes in endogenous prostaglandin 
production could also account for some of the various 
changes in the intracellular pools of CAMP and cGMP 
Abbrevbtions: PHA, phytohaemagglutinin; PGE,, prostaglandin 
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reported to occur soon after the addition of mitogen 
to lymphocytes 112-161. 
We have therefore determined the changes in intra- 
cellular PGEz and PGF, during the period immedi- 
ately following the addition of the mitogen PHA to 
lymphocytes. We have found that there is a rapid but 
transient increase in intracellular PGEz that is maxi- 
mal 30-60 min after the addition of mitogenic con- 
centrations of PHA. There was no corresponding 
early increase in PGF?, at any PHA concentration 
tested;although PGF, levels did increase later in 
culture. Inhibitors of prostaglandin synthesis prevented 
the early increase in PGE2 but did not greatly affect 
other aspects of lymphocyte activation by the mitogen. 
2. Materials and methods 
2.1. fieparation and incubation of lymphocyte cul- 
tures 
Lymphocytes were purified from l-2 1 batches of 
pig blood by a method detailed in [ 171. This method 
includes defibrination, which removes all platelets; 
sedimentation with dextran, to remove most erythro- 
cytes; passage of the cells through a column of cotton 
wool at 37’C to remove phagocytic cells; and separa- 
tion of lymphocytes from residual erythrocytes by 
centrifugation on ficoll-hypaque step gradients. The 
cells obtained by this procedure were at least 99% 
lymphocytes by morphological criteria. They were 
incubated at 37OC at 2 X lo6 cells/ml in Eagle’s 
minimal essential medium containing 15% autologous 
serum. 
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2.2. Extraction and assay of prostaglandins 
The cells were collected by centrifugation, washed 
and resuspended in 0.5 ml 0.15 M NaCl and finally 
broken by freezing and thawing quickly in a mixture 
of dry ice and ethanol. Prostaglandins were extracted 
in 16 vol. ethanol : ether (3 : 1) [ 181 and after centri- 
fugation the upper layer was removed and dried in a 
stream of Nz. The extract was dissolved in phosphate- 
buffered saline and the prostaglandin content was 
determined by a modification of the radioimmuno- 
assay method in [ 191. Three determinations atdif- 
ferent concentrations of extract, each in triplicate, 
were made; Each value given is the mean + SE. The 
standard curve was obtained using known concentra- 
tions of the relevant prostaglandin which had been 
dissolved in ethanol :ether (3: l), dried under a stream 
of N2 and resuspended in buffer. The percentage 
extraction of prostaglandins was 75-80%. 
2.3. Measurement of [%“leucine and /3HJthymidine 
incorporation and / 3H]uridine uptake 
Triplicate 1 ml cultures (2 X IO6 cells/ml) were 
preincubated for 1 h with differing concentrations of
inhibitors of prostaglandin synthesis before the addi- 
tion of PHA (15 pg/ml). [‘y]Leucine and 13H]thy- 
midine were added to a final 1 @i/ml, 4 h and 48 h, 
respectively, after the addition of PHA and their 
incorporation determined after incubation for a further 
2 h. The cells were then harvested, washed with 0.15 M 
NaCl and the trichloroacetic acid-insoluble material 
collected on a glass Bbre filter. The radioactivity 
incorporated was determined using a Beckman scintil- 
lation counter. 
To determine the rate of [aH]uridine uptake cul- 
tures were incubated with 5 &i/ml [3H]uridine for 
1 h at 37’C. Uptake of the isotope was approximately 
linear over this period. The cells were then washed 3 
times with 0.15 M NaCl, lysed by addition of 1 ml 
cold 1% trichloracetic acid, and the acid-soluble 
radioactivity in duplicate 0.25 ml samples determined. 
2.4. Materials 
PHAP was obtained from Difco Laboratories, 
Detroit, MI. Indomethacin, phenylbutazone and aspi- 
rin were purchased from SigmaChemical Co., St Louis, 
MO. Ethanol anal diethyl ether were of Analar grade. 
[methyZ-3H]Thymidine (5 Cilmmol), L-[U-‘~]leucme 
(354 mCi/mmol), [5-3H]uridine (29 Ci/mmol), 
116 
[5,6,8,11,12,14,15(n)-3H]PGE2 and[5,6,8,11,12,14, 
1 5(n)-3H]PGF, (120-l 70 Ci/mmol) were obtained 
from the Radiochemical Centre, Amersham, Bucks. 
3. Results 
3.1. Changes in intracellular concentra)ions of PGEz 
The changes inintracellular concentrations ofPGEz 
during the first 2 h after the addition of PHA to unstim- 
ulated lymphocytes are shown in fig.1. There was a 
distinct rise after 10 min and after 30-60 min there 
was a 7-fold increase over basal evels. In 6 separate 
experiments he maximum increase was 4-7-fold and 
always occurred from 30-60 min. Lymphocytes incu- 
bated with PHA for 6 h or 20 h contained 1.5-2.fold 
more PGEz than unstimulated cells. 
Indomethacin, which is reported to inhibit prosta- 
glandin synthesis [20], was tested to determine 
whether it affected this increase in intracellular levels 
of PGE1. In preliminary experiments with PHA-stim- 
mated lymphocytes incubation for 1 h with 20 MM 
indomethacin was found to substantially reduce intra- 
cellular PGE2. In the experiment shown in fig.2 the 
cells were preincubated for 1 h with 20 @I indo- 
methacin before the addition of PHA. No significant 
increase in PGEz was seen, 
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Fig.1. Changes in intracellular concentrations of PGE, 
during the first 2 h after addition of PHA (15 fig/ml). The 
concentration of PGE, after 20 h was 2.67 f 0.25 pmol/lO’ 
cells. 
Volume 94, number 1 FEBS LETTERS October 1978 
I - 
0 1 
Hours 
L 
2 
Fig.2. Effect of indomethacin on intracellular PGE, concen- 
trations. Cells were preincubated for 1 h with 20 NM indo- 
methacin before the addition of PHA (15 ccg/ml) at time 0. 
Intracellular PGE, concentration after 20 h in the presence 
of PHA was 1.03 + 0.096 pmol/lO’ cells. 
When the effect of different concentrations of
PHA on the increase in intracellular PGEa content 
after incubation with PHA for 30 min was studied, a 
direct relationship was found between intracellular 
PGEs content and PHA Q 15 L(g PHA/ml. Addition 
of further PHA did not further increase the level of 
intracellular PGE?. At PHA < 1.5 pg/ml there was 
little or no increase in intracellular PGEs content 
over the level found in unstimulated lymphocytes. 
Three such experiments gave essentially similar esults. 
3.2. Changes in intracellular concentrations of PGF, 
There was no early increase in intracellular levels 
of PGF2(, comparable to that found to PGEz (fig.3). 
The intracellular PGF, content was not satistically 
different from the unstimulated level at any time 
within 2 h of the addition of PHA. After incubation 
for 20 h with PHA there was an increase which varied 
2-7-fold over that found in unstimulated lympho- 
cytes in 5 separate xperiments. 
No concentration of PHA in the range tested pro- 
duced an early increase in intracellular PGFs, concen- 
tration (fig.4). At 3.75 pg/ml and 7.5 pg/ml PHA the 
amount of PGFzo, present in the cells was slightly 
reduced. Three such experiments gave essentially 
similar esults. 
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Fig.3. Changes in intracellular concentrations of PGF,, in the 
first 2 h after addition of PHA (15 fig/ml). After 20 h the 
intracellular PGF,, content was 7.2 f 0.28 pmol/lO* cells. 
3.3. Effect of inhibitors of prostaglandin synthesis on 
lymphocyte activation 
Table 1 shows the effect of 3 drugs reported to 
inhibit prostaglandin synthesis on [‘HJthymidine 
incorporation into DNA by PHA-stimulated lympho- 
cytes. At none of the concentrations tested was there 
complete inhibition of [3H]thymidine incorporation. 
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Fii.4. Changes in intracellular PGF,, concentrations in cells 
incubated with different concentrations of PHA for 30 min. 
After 20 h in the presence of PHA (15 pg/ml) the intra- 
cellular PGF,, content was 4.28 * 0.16 pmol/lOs cells. 
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Tabie 1 
Effect of inhibitors of prostaglandin synthesis on 
[“Hlthymidine incorporation by PHA-stimulated cells 
Inhibitor cpm x lo4 ?: SD % Inhib. 
Control - PHA 
Control + PHA 
Indomethacin 
1rM 
5N 
20 PM 
Phenylbutazone 
5/JM 
10nM 
50 HIM 
Aspirin 
l@ 
5lJM 
20 rM 
501rM 
0.12 -f 0.01 
3.51 f 0.25 
3.09 f 0.25 12 
2.88 +_ 0.21 18 
2.71 * 0.15 23 
3.01 f 0.21 14 
2.91 f. 0.18 17 
2.88 * 0.22 18 
3.28 +_ 0.27 6 
2.94 f 0.22 16 
2.61 f 0.21 24 
1.95 + 0.17 44 
_ 
_ 
Each value is the average of 3 determinations. Each culture 
contained 15 fig/ml PHA. The inhibitors were dissolved in 
ethand : Eagles medium, 1: 10 (v/v). The control cultures 
contained equivalent volumes of ethanol : Eagles. Three 
such experiments gave essentially similar results 
With 20 r_iM indomethacin, which we have shown 
completely inhibits the early rise in intracellular 
PGEz content (fig.2), there was only 23% ~hibition 
of [3H]thymidine incorporation. Similar inhibition 
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Fig.5. Effects of indomethacin of (A) [ ‘Hluridine uptake 
into the acid-soluble fraction by lymphocytes incubated 
with or without PHA for 1 h and (B) f “C]leucine incorpora- 
tion into protein b$ lymphocytes incubated with PHA for 
6 h. Cells were preincubated with indomethacin for 1 h 
before the addition of PHA at time 0. (e) Cultures with PHA. 
(o) Cultures without PHA. 
was seen with phenylbutazone. The greatest inhibi- 
tion (44%) was shown by 50 &I aspirin, 
Figure 5 shows the effect of indomethacin on 
L3H]uridine uptake in the first hour after the addi- 
tion of PHA and on [ 14C Jleucine incorporation into 
protein after 6 h stimulation with PHA. In neither 
case was there any significant effect of’indomethacin 
on the mitogen-dependent increases seen. 
4. Discussion 
The large early transient increases in intracellular 
PGEz observed in lymphocytes incubated with PHA 
in this study have not been reported previously. How- 
ever, long term changes in medium concentrations of
PGEz compatible with the increase we observed after 
20 h in the presence of PHA have been seen in both 
serum-stimulated fibroblasts and mitogen-stimulated 
mouse spleen cells [7,8]. We did not find any early 
transient increase in F, as has been reported in whole 
spleens in sensitized mice injected with antigen [9,10], 
but did observe a later and rather variable rise as has 
been seen by others in serum-stimulated fibroblasts [ 21 J. 
The transient rise in PGEz correlates with, and may 
be the cause of, the increase in CAMP seen by some 
[13,15,22] but not all [12,14] workers. However, 
the role of prostagl~d~s could be unrelated to their 
effect on cyclic nucleotides as endogenously produced 
prostaglandins may function as regulators of cell 
division per se [23]. 
Indomethacin and aspirin, two inhibitors of pros- 
taglandin synthesis, have been reported to inhibit 
st~ulation of DNA synthesis in ~rurn-steward 
fibroblasts and mitogen-stimulated lymphocytes, res- 
pectively [ 1,l I]. However, at concentrations reported 
to inhibit prostaglandin synthetase completely both 
these compounds and phenylbutazone , another pros- 
taglandin synthesis inhibitor f 123,241, only partly 
i~bited PHA-stimulated ~3H~~y~dine incorpora- 
tion. It is difficult to be certain that the inhibition of 
prostaglandin synthesis i  fully maintained over the 
48 h culture period required for measurement of 
DNA synthesis or that the inhibitions een in these 
experiments are not due to secondary effects of the 
drugs, However, the concentration of indomethacin 
which abolishes the early transient rise in PCEz does 
not affect the simultaneous increase in uridine uptake 
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Volume 94, number 1 FEBS LETTERS October 1978 
or early increase in protein synthesis seen a few hours 
later. We have, therefore, been unable to conclude 
that the early transient rise in PGEs observed is 
necessary for the mitogenic response to PHA. It may, 
however, be related to other Tcell functions induced 
by mitogens such as acquisition of suppressor cell 
function [25]. 
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